← Compounds
Oxytocin
peptide · headlineFDA-approvedBinds to oxytocin receptors (OXTR) in the uterus and brain
Summary
Oxytocin is a nonapeptide hormone that promotes uterine contraction, lactation, and emotional bonding. Intranasal oxytocin is under investigation for its effects on social cognition, emotional regulation, and conditions like autism and anxiety. It modulates brain circuits related to trust, fear, and empathy.
How it works
- Binds to oxytocin receptors (OXTR) in the uterus and brain
- Triggers intracellular calcium release, causing muscle contraction
- Activates regions of the brain linked to empathy, trust, and bonding
- Modulates social cognition and fear response in the amygdala
Dosing
- unit: IUlow dose: 12frequency: Varies; often 2–3 times daily for behavioral usehigh dose: 48standard dose: 24administration route: Intranasal
Cycling
- Apply 1–2 sprays per nostril up to 3x daily. Use in 5-on/2-off cycles or as needed for social and emotional regulation.
Side effects
common: ["Nasal irritation and discomfort (14% in trials)","Headache (10%), dry mouth, runny nose","Burning sensation in nose (10%), lightheadedness","Irritability (9%), tiredness (7%)"]
Chemistry & PK
sequence: CYIQNCPLG
half life: 3–5 minutes in peripheral blood
degradation: Cleared rapidly via hepatic and renal enzymatic breakdown
molecular weight: 1007.19
molecular formula: C43H66N12O12S2
tissue specificity: Acts centrally in the hypothalamus and limbic system, peripherally in uterus and mammary tissue
Verified citations
2 · PubMed-checked- The Oxytocin Receptor: From Intracellular Signaling to Behavior.mechanismPMID 29897293 ↗
- Oxytocin, Neural Plasticity, and Social Behavior.reviewPMID 33823654 ↗
Used for
Legal / compounding
FDA-approved
Legal status is a hard gate: non-compoundable or delisted agents cannot be filled and are blocked from protocol export. Keep 503A status current.